---
layout: post
title: "诚志股份：RiaGEV经过肝脏代谢转化成NMN和NR 继而生成NAD+"
date: 2022-04-18 17:05:23 +0800
categories: meirijingjixinwen
tags: 每日经济新闻新闻
---
<p style="display:none;height:1px;overflow:hidden;"><br /></p><!-- EM_StockImg_Start --><p style="text-align:center;"><a href="http://quote.eastmoney.com/unify/r/0.000990" data-code="000990|0|2" data-code2="000990|0|6|" class="EmImageRemark" target="_blank"><img src="https://webquoteklinepic.eastmoney.com/GetPic.aspx?nid=0.000990&imageType=k&token=28dfeb41d35cc81d84b4664d7c23c49f&at=1" border="0" alt="K图 000990_0" data-code="K 000990|0|2" data-code2="K 000990|0|6|" style="border:#d1d1d1 1px solid;" width="578" height="276" /></a></p><!-- EM_StockImg_End --><p>每经AI快讯，有投资者在投资者互动平台提问：请问董秘，旗下BIOENERGY LIFE SCIENCE.，INC.公司的产品“RiaGEV”是否属于NMN不老药？能否介绍一下相关技术原理？谢谢。<br /></p><p>诚志股份(000990.SZ)4月18日在投资者互动平台表示，RiaGEV经过肝脏代谢转化成NMN和NR，继而生成NAD+。</p><p class="em_media">（文章来源：每日经济新闻）</p>

<http://finews.zning.xyz/html_News/NewsShare.html?infoCode=NW202204182346938547>

[返回每日经济新闻新闻](//finews.withounder.com/category/meirijingjixinwen.html)｜[返回首页](//finews.withounder.com/)